We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+16.08%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$232M
AUM Growth
-$281M
Cap. Flow
-$304M
Cap. Flow %
-130.94%
Top 10 Hldgs %
35.11%
Holding
133
New
10
Increased
39
Reduced
47
Closed
29

Top Buys

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$4.1M
2
SLRN
ACELYRIN
SLRN
+$2.78M
3
MRK icon
Merck
MRK
+$2.54M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$2.3M
5
TVTX icon
Travere Therapeutics
TVTX
+$2M

Top Sells

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$11.2M
2
BPMC
Blueprint Medicines
BPMC
+$10.6M
3
HQY icon
HealthEquity
HQY
+$10.5M
4
EVH icon
Evolent Health
EVH
+$10.4M
5
RDNT icon
RadNet
RDNT
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 99.21%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
26
Icon
ICLR
$12.6B
$2.89M 1.24%
10,203
-23,460
-70% -$6.07M
FDMT icon
27
4D Molecular Therapeutics
FDMT
$532M
$2.89M 1.24%
+142,510
New +$1.87M
PODD icon
28
Insulet
PODD
$11.5B
$2.81M 1.21%
12,950
-23,775
-65% -$4.08M
ARVN icon
29
Arvinas
ARVN
$518M
$2.72M 1.17%
66,000
+58,990
+842% +$1.38M
STRO icon
30
Sutro Biopharma
STRO
$401M
$2.68M 1.15%
62,368
+19,134
+44% +$607K
REPL icon
31
Replimune Group
REPL
$941M
$2.57M 1.11%
305,412
+34,356
+13% +$398K
TVTX icon
32
Travere Therapeutics
TVTX
$5.2B
$2.47M 1.06%
+274,623
New +$2M
GDRX icon
33
GoodRx Holdings
GDRX
$1.04B
$2.44M 1.05%
364,000
-643,000
-64% -$3.62M
SLRN
34
DELISTED
ACELYRIN
SLRN
$2.43M 1.05%
+325,549
New +$2.78M
ITOS
35
DELISTED
iTeos Therapeutics
ITOS
$2.41M 1.04%
220,056
+64,981
+42% +$644K
FOLD
36
DELISTED
Amicus Therapeutics
FOLD
$2.22M 0.96%
156,769
-646,695
-80% -$7.34M
OPCH icon
37
Option Care Health
OPCH
$3.45B
$2.16M 0.93%
64,000
-311,500
-83% -$9.57M
PMVP icon
38
PMV Pharmaceuticals
PMVP
$59.2M
$2.13M 0.92%
685,985
+382,161
+126% +$1.01M
PRVA icon
39
Privia Health
PRVA
$2.98B
$2.08M 0.9%
90,310
-404,312
-82% -$9.05M
SRPT icon
40
Sarepta Therapeutics
SRPT
$1.57B
$2.08M 0.89%
21,541
+3,535
+20% +$339K
ALLK
41
DELISTED
Allakos
ALLK
$2.05M 0.88%
752,381
-17,751
-2% -$40K
AXNX
42
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.04M 0.88%
32,800
-140,150
-81% -$7.84M
SNDX icon
43
Syndax Pharmaceuticals
SNDX
$1.69B
$1.99M 0.86%
+92,060
New +$1.42M
CNMD icon
44
CONMED
CNMD
$1.39B
$1.98M 0.85%
18,100
-95,900
-84% -$9.92M
QURE icon
45
uniQure
QURE
$3.03B
$1.98M 0.85%
+292,592
New +$1.93M
SPRY icon
46
ARS Pharmaceuticals
SPRY
$509M
$1.94M 0.84%
354,641
-694,550
-66% -$3.04M
ALT icon
47
Altimmune
ALT
$552M
$1.92M 0.83%
+170,800
New +$713K
VERA icon
48
Vera Therapeutics
VERA
$2.3B
$1.91M 0.82%
124,151
-232,988
-65% -$2.96M
EYPT icon
49
EyePoint Inc
EYPT
$1.03B
$1.88M 0.81%
81,160
-94,920
-54% -$1.06M
RCUS icon
50
Arcus Biosciences
RCUS
$3.55B
$1.86M 0.8%
97,435
-278,021
-74% -$4.44M
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Sectoral Asset Management held 133 positions worth $232M, down 55% from $514M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Sectoral Asset Management withdrew a net $304M in Q4 2023, closing 29 positions and reducing 47 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier, followed by Industrials.

Against the trend, Sectoral Asset Management opened a new position in ACELYRIN worth $2.43M.

  • Sectoral Asset Management's largest Q4 2023 buy was ACELYRIN: 325,549 shares worth $2.43M.
  • Sectoral Asset Management added most to argenx in Q4 2023, an estimated $4.1M increase.
  • Sectoral Asset Management's biggest Q4 2023 reduction was Blueprint Medicines, cutting an estimated $10.6M.
  • Sectoral Asset Management fully exited R1 RCM Inc. Common Stock in Q4 2023, selling an estimated $11.2M.
  • Sectoral Asset Management's ten largest holdings make up 35% of its $232M portfolio in Q4 2023.
  • Sectoral Asset Management opened 10 new positions and closed 29 in Q4 2023.
  • Sectoral Asset Management's portfolio value fell 55% quarter-over-quarter to $232M.

Based on Sectoral Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.